{"id":"https://openalex.org/W2403790973","doi":null,"title":"Trends in erythropoietin therapy in the U.S. dialysis population: 1995 to 1998.","display_name":"Trends in erythropoietin therapy in the U.S. dialysis population: 1995 to 1998.","publication_year":2000,"publication_date":"2000-07-01","ids":{"openalex":"https://openalex.org/W2403790973","mag":"2403790973","pmid":"https://pubmed.ncbi.nlm.nih.gov/10928335"},"language":"en","primary_location":{"id":"pmid:10928335","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10928335","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in nephrology","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109255494","display_name":"Paul L. Kimmel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P L Kimmel","raw_affiliation_strings":["Department of Medicine, George Washington University Medical Center, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, George Washington University Medical Center, Washington, DC, USA","institution_ids":["https://openalex.org/I193531525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062567076","display_name":"Greer Jw","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J W Greer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082584003","display_name":"Robert Alden Milam","orcid":"https://orcid.org/0000-0002-1507-792X","observed_orcids":["https://orcid.org/0000-0002-1507-792X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R A Milam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5059642911","display_name":"Mae Thamer","orcid":"https://orcid.org/0000-0002-7559-7193","observed_orcids":["https://orcid.org/0000-0002-7559-7193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Thamer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5427,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.67347634,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"20","issue":"4","first_page":"335","last_page":"44"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recombinant-human-erythropoietin","display_name":"recombinant human erythropoietin","score":0.9789999723434448},{"id":"https://openalex.org/keywords/dialysis","display_name":"dialysis","score":0.6230000257492065},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.9599999785423279},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.7239999771118164},{"id":"https://openalex.org/keywords/intravenous-iron","display_name":"intravenous iron","score":0.7839999794960022},{"id":"https://openalex.org/keywords/hematocrit","display_name":"hematocrit","score":0.9900000095367432},{"id":"https://openalex.org/keywords/medicare-spending","display_name":"Medicare spending","score":0.7459999918937683},{"id":"https://openalex.org/keywords/payment-regulation","display_name":"payment regulation","score":0.38999998569488525},{"id":"https://openalex.org/keywords/iron-deficiency","display_name":"iron deficiency","score":0.6349999904632568},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.9490000009536743},{"id":"https://openalex.org/keywords/treatment-trends","display_name":"treatment trends","score":0.3409999907016754}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9293105602264404},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.8148044943809509},{"id":"https://openalex.org/C2780959883","wikidata":"https://www.wikidata.org/wiki/Q111146","display_name":"Hematocrit","level":2,"score":0.7252680063247681},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.6981942057609558},{"id":"https://openalex.org/C2779978075","wikidata":"https://www.wikidata.org/wiki/Q202301","display_name":"Dialysis","level":2,"score":0.6664901971817017},{"id":"https://openalex.org/C3019040382","wikidata":"https://www.wikidata.org/wiki/Q476921","display_name":"End stage renal disease","level":3,"score":0.5622051358222961},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49409058690071106},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.4618040919303894},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4580596387386322},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.45204004645347595},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006435","descriptor_name":"Renal Dialysis","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006435","descriptor_name":"Renal Dialysis","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012042","descriptor_name":"Registries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018798","descriptor_name":"Anemia, Iron-Deficiency","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018798","descriptor_name":"Anemia, Iron-Deficiency","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10928335","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10928335","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in nephrology","raw_type":"Journal Article"},{"id":"mag:2403790973","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10928335","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2069420636","https://openalex.org/W2993921320","https://openalex.org/W2082812841","https://openalex.org/W2266646096","https://openalex.org/W2070612539","https://openalex.org/W2049646249","https://openalex.org/W152427216","https://openalex.org/W2411438354","https://openalex.org/W2072371718","https://openalex.org/W2167311916"],"abstract_inverted_index":{"Anemia":[0],"is":[1,38],"an":[2],"important":[3],"cause":[4],"of":[5,33,64,79,85,116,125,152,166,171],"morbidity,":[6],"and":[7,42,62,122,158,160,175],"may":[8],"be":[9,58],"associated":[10],"with":[11,16,24],"increased":[12,69,91],"mortality":[13],"in":[14,112,134,138],"patients":[15,66,90,126],"end-stage":[17],"renal":[18],"disease":[19],"(ESRD)":[20],"receiving":[21,67,127],"dialysis.":[22],"Therapy":[23],"recombinant":[25],"human":[26],"erythropoietin":[27],"(rHuEPO)":[28],"has":[29,132],"revolutionized":[30],"the":[31,49,77,94,107,114,123,139,164,179],"care":[32],"ESRD":[34,65],"patients,":[35],"but":[36,103],"this":[37,130,145],"a":[39,135,150,169],"costly":[40],"medication":[41],"concerns":[43],"have":[44],"been":[45],"expressed":[46],"about":[47],"whether":[48],"outcome,":[50],"as":[51,75,168],"measured":[52],"by":[53],"achieved":[54],"hematocrit":[55,100],"(Hct),":[56],"could":[57],"improved.":[59],"The":[60,83,97,110],"number":[61,124],"proportion":[63],"rHuEPO":[68,80,128],"steadily":[70],"from":[71],"1995":[72],"to":[73,89,142,163],"1998,":[74],"did":[76],"dose":[78],"per":[81,118],"patient.":[82],"amount":[84],"intravenous":[86],"iron":[87,173],"administered":[88],"markedly":[92],"over":[93,106,129],"study":[95,108],"period.":[96,109],"patients'":[98],"mean":[99],"also":[101],"rose,":[102],"proportionally":[104],"less":[105],"increase":[111,137],"both":[113,172],"amounts":[115],"payments":[117],"patient":[119,161],"for":[120,144],"rHuEPO,":[121,167],"time":[131],"resulted":[133],"marked":[136],"total":[140],"costs":[141],"Medicare":[143],"therapy.":[146],"We":[147],"suggest":[148],"that":[149],"combination":[151],"payment":[153],"regulations,":[154],"provider":[155],"financial":[156],"opportunities":[157],"disincentives,":[159],"resistance":[162],"effects":[165],"result":[170],"deficiency":[174],"inflammation,":[176],"largely":[177],"explain":[178],"findings.":[180]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}